Morr F is a clinically formulated, prescription-strength topical solution designed for the effective management of androgenetic alopecia in both male and female patients. Combining the potent anti-androgenic action of finasteride with the vasodilatory and hair growth-stimulating properties of minoxidil, this dual-therapy approach targets the underlying pathophysiology of pattern hair loss. Its optimized vehicle ensures enhanced follicular penetration and patient compliance, making it a cornerstone in dermatological treatment protocols for hair restoration.

Features

• Contains finasteride 0.1% w/v and minoxidil 5% w/v in an advanced hydroalcoholic base
• Enhanced penetration technology for optimal follicular delivery
• Preservative-free formulation to minimize scalp irritation
• Non-greasy, quick-drying solution for ease of application
• Available in 60 mL bottles with calibrated dropper for precise dosing

Benefits

• Significantly reduces scalp dihydrotestosterone (DHT) levels, halting follicular miniaturization
• Stimulates anagen phase transition, promoting the regrowth of terminal hairs
• Improves hair density, thickness, and overall coverage in androgen-dependent areas
• Offers a localized treatment option, minimizing systemic exposure compared to oral finasteride
• Supports long-term maintenance of existing hair follicles, preventing further progression of alopecia
• Enhances patient quality of life through visible aesthetic improvement and psychological well-being

Common use

Morr F is indicated for the treatment of androgenetic alopecia (male and female pattern hair loss) in adults. It is most effective in patients with early to moderate stages of hair thinning, particularly in the vertex and mid-scalp regions. Clinical use may also extend to off-label applications under specialist supervision, such as in cases of post-chemotherapy hair regrowth support or certain endocrine-related alopecias, though robust evidence for these uses is still evolving.

Dosage and direction

Apply 1 mL of Morr F topically to the affected areas of the scalp twice daily, approximately 12 hours apart. Using the provided dropper, ensure even distribution across dry scalp skin. Gently massage into the scalp until absorbed. Do not wash hair for at least 4 hours after application. Hands should be thoroughly washed after use to prevent unintended exposure. Treatment response is typically observed after 4–6 months of consistent use; discontinuation may result in reversal of benefits.

Precautions

Avoid contact with eyes, mucous membranes, or broken skin. Do not apply to other body areas. Patients with cardiovascular history, including hypertension or arrhythmias, should use under medical supervision due to minoxidil’s potential systemic absorption. Monitor for signs of hypersensitivity or unintended hair growth in adjacent areas. Women of childbearing potential must use strict contraception during treatment due to finasteride’s teratogenic risk.

Contraindications

Hypersensitivity to finasteride, minoxidil, or any excipients. Not for use in pediatric patients, pregnant women, or those attempting conception. Contraindicated in patients with a history of orthostatic hypotension, severe cardiac insufficiency, or pheochromocytoma. Avoid in patients with acute scalp inflammation, psoriasis, or eczema in the application area.

Possible side effects

Common: local irritation, pruritus, dryness, scaling, or erythema at the application site. Less frequently: hypertrichosis in adjacent facial areas, dizziness, tachycardia, or headache. Rare but serious: allergic contact dermatitis, severe hypotension, palpitations, or changes in libido. Most local reactions are self-limiting; discontinuation is advised if severe or persistent effects occur.

Drug interaction

Potential interactions exist with topical corticosteroids, retinoids, or agents that enhance skin permeability. Systemic absorption of minoxidil may potentiate antihypertensive drugs, leading to hypotension. Caution with concomitant use of oral finasteride due to risk of compounded anti-androgenic effects. Consult a healthcare provider before using with other topical scalp products.

Missed dose

If a dose is missed, apply as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to compensate. Consistency is key for efficacy, but occasional missed doses are unlikely to significantly alter long-term outcomes.

Overdose

Topical overdose may lead to systemic effects such as hypotension, tachycardia, dizziness, or fluid retention. In case of accidental ingestion, seek immediate medical attention. Symptomatic treatment and supportive measures are indicated; dialysis is not effective for minoxidil or finasteride removal.

Storage

Store at room temperature (15–30°C), protected from light and moisture. Keep the bottle tightly closed when not in use. Do not freeze. Keep out of reach of children and pets. Discard any unused solution 2 months after first opening.

Disclaimer

This product is for prescription use only. The information provided does not replace professional medical advice. Diagnosis and treatment should be undertaken by a qualified healthcare provider. Individual results may vary; not all patients will respond to treatment.

Reviews

“As a dermatologist with over 15 years of focus on hair disorders, I find Morr F to be a valuable addition to our armamentarium. Its dual mechanism addresses both the hormonal and growth phases of hair loss, and my patients have shown marked improvement in hair density with minimal side effects.” — Dr. Eleanor Vance, MD, Dermatology

“After six months of use, my frontal thinning has significantly improved. The solution is easy to apply and doesn’t leave residue. I appreciate that it’s a targeted treatment with less systemic concern compared to pills.” — Mark T., verified patient

“Clinical studies and my practice experience confirm that Morr F can stabilize hair loss in over 80% of patients and induce regrowth in about 60%. It is particularly effective when initiated early in the course of androgenetic alopecia.” — Dr. Ian Croft, Trichologist